Therefore, it is necessary to further study TRIP6 to elucidate its potential connection with glycolysis, angiogenesis, and immune infiltration in CRC, which will ultimately contribute to the advancement of cancer treatment and improve patient prognosis. This evidence concerns the gene TRIP6 and colorectal carcinoma.